NCT01697566 2025-06-11
An Endometrial Cancer Chemoprevention Study of Metformin
M.D. Anderson Cancer Center
Phase 3 Completed
Clinical Trials
6 trialsNCT01832402 2023-06-08
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01952847 2022-06-15
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01670097 2021-02-17
Dexamethasone Dyspnea Study
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01856114 2020-09-16
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01515566 2014-08-22
Breakthrough Dyspnea Fentanyl Study in Cancer Patients
M.D. Anderson Cancer Center
Phase 1/2 Completed